Download presentation
Presentation is loading. Please wait.
Published byFrederica Blair Modified over 8 years ago
1
Pharmacovigilance respect to ARV 23 -28 th 2009 White sand Hotel, Dar es salaam
2
BY MOHAMMED O.M.SIMBA Focal person PV - Zanzibar
3
PV Activities in Zanzibar There is a Pharmacovigilance center which operates under ZFDB Several HWs have been trained Guidelines for PV were developed Tool for data collection forms (ADR report) were developed Introduce PV boxes in all hospital departments include HIV/AIDs We have add PV in c/o student curriculum.
4
Data Management Patient report forms whenever available are regularly collected and submitted to PV Center EPI INFO is used for data entry and analysis Currently we have enrolled for access to VigiFlow, we do not have much experience on it
5
PV in public health programme/HIV treatment programme We do not have special programme for Antiretroviral but all patient are monitored. Two staff were trained for Pharmacovigilance in a HIV/AIDs department.
6
ARVs most used in HIV national center Zidovudine +Lamivudine +Efavirez Stavudine + Lamividine +Efavirez Abacavir + Didanosine + lopenavir Tenofovir + Emitricitabine +lopenavir 3699 patients are attending CTCs, 1794 are on ARVs, 24 are on second line ARVs.
7
ARV – ADR reports Fewer have been reported
8
PV activities in ARV There is no special or strategies for PV activities in HIV/AIDs.
9
Way forward There is need for HIV/AIDs programme to have special budgeted Pharmacovigilance Activities like Malaria Control programme.
10
Report all ADRs as soon as possible AHSANTE
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.